Filtros de búsqueda

Lista de obras de Charlotte Charpentier

A new mechanism of resistance of HIV-2 to integrase inhibitors: a 5 amino-acids insertion in the integrase C-terminal domain

article

Antiretroviral-Experienced HIV-1-Infected Patients Treated with Maraviroc: Factors Associated with Virological Response

artículo científico publicado en 2014

Association of Soluble CD14 and Inflammatory Biomarkers With HIV-2 Disease Progression ⬇️

artículo científico publicado el 20 de agosto de 2012

Baseline genotypic and phenotypic susceptibilities of HIV-1 group O to enfuvirtide

artículo científico publicado en 2010

Budget impact of antiretroviral therapy in a French clinic cohort

artículo científico publicado en 2017

Cellular HIV-1 DNA quantification and short-term and long-term response to antiretroviral therapy ⬇️

artículo científico publicado el 27 de abril de 2011

Cenicriviroc, a Novel CCR5 (R5) and CCR2 Antagonist, Shows In Vitro Activity against R5 Tropic HIV-2 Clinical Isolates

artículo científico publicado en 2015

Change in HIV-1 DNA tropism despite virological success in patients receiving an enfuvirtide-based regimen

artículo científico publicado en 2014

Characterization of CRF56_cpx, a new circulating B/CRF02/G recombinant form identified in MSM in France

artículo científico publicado en 2013

Combinatorial prevention of HIV transmission in women: the case for a vaginal microbicide

artículo científico publicado en 2011

Concordance between HIV-2 genotypic coreceptor tropism predictions based on plasma RNA and proviral DNA

article

Cross-resistance to elvitegravir and dolutegravir in 502 patients failing on raltegravir: a French national study of raltegravir-experienced HIV-1-infected patients

artículo científico publicado en 2015

Description of the L76V resistance protease mutation in HIV-1 B and "non-B" subtypes

artículo científico publicado en 2013

Differential activity of candidate microbicides against early steps of HIV-1 infection upon complement virus opsonization

artículo científico publicado en 2010

Distribution of HIV-1 and HSV-2 epidemics in Chad revealing HSV-2 hot-spot in regions of high-risk HIV spread.

artículo científico publicado en 2011

Dolutegravir in HIV-2-Infected Patients With Resistant Virus to First-line Integrase Inhibitors From the French Named Patient Program

artículo científico publicado en 2015

Dynamics of enfuvirtide resistance mutations in enfuvirtide-experienced patients remaining in virological failure under salvage therapy.

artículo científico

Dynamics of gag-pol minority viral populations in naive HIV-1-infected patients failing protease inhibitor regimen ⬇️

artículo científico publicado el 13 de noviembre de 2011

Early archives of genetically-restricted proviral DNA in the female genital tract after heterosexual transmission of HIV-1.

artículo científico publicado en 2007

Efficiency of HIV-2 cultures from clinical isolates is enhanced after purification by anti-CD44 microbeads

artículo científico publicado en 2018

Epidemiological Profile of Newly Diagnosed HIV-Infected Patients in Northern Paris: A Retrospective Study

artículo científico publicado en 2016

Evaluation of different analysis pipelines for the detection of HIV-1 minority resistant variants.

artículo científico publicado en 2018

Evaluation of four tenofovir-containing regimens as first-line treatments in Cameroon and Senegal: the ANRS 12115 DAYANA Trial

artículo científico publicado en 2013

Evaluation of the genotypic prediction of HIV-1 coreceptor use versus a phenotypic assay and correlation with the virological response to maraviroc: the ANRS GenoTropism study

artículo científico publicado en 2010

Evolution of the K65R, K103N and M184V/I reverse transcriptase mutations in HIV-1-infected patients experiencing virological failure between 2005 and 2010.

artículo científico publicado en 2013

Extended use of raltegravir in the treatment of HIV-1 infection: optimizing therapy ⬇️

artículo científico publicado el 13 de octubre de 2010

Extensive recombination among human immunodeficiency virus type 1 quasispecies makes an important contribution to viral diversity in individual patients

artículo científico publicado en 2006

Factors associated with virological response to etravirine in nonnucleoside reverse transcriptase inhibitor-experienced HIV-1-infected patients

artículo científico publicado en 2009

First line raltegravir/emtricitabine/tenofovir combination in HIV-2 infection: phase 2 non-comparative trial (ANRS 159 HIV-2).

artículo científico publicado en 2018

Foscarnet as salvage therapy in HIV-2-infected patient with antiretroviral treatment failure.

artículo científico publicado en 2009

Foscarnet salvage therapy efficacy is associated with the presence of thymidine-associated mutations (TAMs) in HIV-infected patients

artículo científico publicado en 2008

Foscarnet, zidovudine and dolutegravir combination efficacy and tolerability for late stage HIV salvage therapy: A case-series experience

artículo científico publicado en 2015

Functional diversity of HIV-1 envelope proteins expressed by contemporaneous plasma viruses

artículo científico publicado en 2008

G140S/Q148R and N155H mutations render HIV-2 Integrase resistant to raltegravir whereas Y143C does not.

artículo científico publicado en 2011

Genetic barrier for attachment inhibitor BMS-626529 resistance in HIV-1 B and non-B subtypes

artículo científico publicado en 2014

Genotypic resistance profiles of HIV-2-treated patients in West Africa

artículo científico publicado en 2014

HIV-1 Coreceptor Usage Assessment by Ultra-Deep Pyrosequencing and Response to Maraviroc

artículo científico publicado en 2015

HIV-1 DNA ultra-deep sequencing analysis at initiation of the dual therapy dolutegravir + lamivudine in the maintenance DOLULAM pilot study

artículo científico publicado en 2017

HIV-1 group O infection in France: clinical features and immunovirological response to antiretrovirals

artículo científico publicado en 2017

HIV-2 Primary Infection in a French 69-Year-Old Bisexual Man

article

HIV-2 Vif Diversity Among Defective and Nondefective Sequences

artículo científico publicado en 2015

HIV-2 X4 tropism is associated with lower CD4+ cell count in treatment-experienced patients

artículo científico publicado en 2014

HIV-2EU-Supporting Standardized HIV-2 Drug-Resistance Interpretation in Europe: An Update

artículo científico publicado en 2015

HIV-2EU: supporting standardized HIV-2 drug resistance interpretation in Europe

artículo científico publicado en 2013

HPV 16 in squamous cell carcinoma of 19th century tonsils

artículo científico publicado en 2016

High frequency of antiretroviral drug resistance among HIV-infected adults receiving first-line highly active antiretroviral therapy in N'Djamena, Chad

artículo científico publicado en 2009

High frequency of integrase Q148R minority variants in HIV-infected patients naive of integrase inhibitors.

artículo científico publicado en 2010

High level of APOBEC3F/3G editing in HIV-2 DNA vif and pol sequences from antiretroviral-naive patients

artículo científico publicado en 2015

High predictive efficacy of integrase strand transfer inhibitors in perinatally HIV-1-infected African children in therapeutic failure of first- and second-line antiretroviral drug regimens recommended by the WHO.

artículo científico publicado en 2019

High prevalence of antiretroviral drug resistance among HIV-1-untreated patients in Guinea-Conakry and in Niger

artículo científico publicado en 2011

High prevalence of antiretroviral drug resistance mutations in HIV-1 non-B subtype strains from African children receiving antiretroviral therapy regimen according to the 2006 revised WHO recommendations

artículo científico publicado en 2008

High rate of antiretroviral drug resistance mutations in HIV type 1-infected Senegalese children in virological failure on first-line treatment according to the World Health Organization guidelines

artículo científico publicado en 2012

High virological suppression regardless of the genotypic susceptibility score after switching to a dolutegravir-based regimen: week 48 results in an observational cohort.

artículo científico publicado en 2018

Highly frequent HIV-1 minority resistant variants at baseline of the ANRS 139 TRIO trial had a limited impact on virological response

artículo científico publicado en 2015

Hiv-2 molecular epidemiology

artículo científico publicado en 2016

Hot spots of integrase genotypic changes leading to HIV-2 resistance to raltegravir

artículo científico publicado en 2010

Identification of a rare mutation at reverse transcriptase Lys65 (K65E) in HIV-1-infected patients failing on nucleos(t)ide reverse transcriptase inhibitors

artículo científico publicado en 2013

Illegal gold miners in French Guiana: a neglected population with poor health

artículo científico publicado en 2017

Impact of Adding Enfuvirtide to the Predictive Value of the Darunavir Genotypic Resistance Score

artículo científico publicado en 2011

Impact of HIV-1 group O genetic diversity on genotypic resistance interpretation by algorithms designed for HIV-1 group M.

artículo científico publicado en 2011

Impact of HIV-1 minority variants on the virus response to a rilpivirine-based first line regimen

artículo científico publicado en 2017

Impact of gag genetic determinants on virological outcome to boosted lopinavir-containing regimen in HIV-2-infected patients

artículo científico publicado en 2013

Impact of lopinavir/ritonavir use on antiretroviral resistance in recent clinical practice

artículo científico publicado en 2012

Impact of natural polymorphisms of HIV-1 non-group M on genotypic susceptibility to the attachment inhibitor fostemsavir

article

Impact of obesity on antiretroviral pharmacokinetics and immuno-virological response in HIV-infected patients: a case-control study

artículo científico publicado en 2017

In vitro phenotypic susceptibility of HIV-2 clinical isolates to CCR5 inhibitors

artículo científico publicado en 2011

In vitro synergistic activity against CCR5-tropic HIV-1 with combinations of potential candidate microbicide molecules HHA, KRV2110 and enfuvirtide (T20).

artículo científico publicado en 2009

In-vitro phenotypic susceptibility of HIV-1 'non-B' integrase inhibitors naive clinical isolates to dolutegravir and raltegravir

artículo científico publicado en 2013

In-vitro phenotypic susceptibility of HIV-2 clinical isolates to the integrase inhibitor S/GSK1349572.

artículo científico publicado en 2010

Increased Polymorphism in the HR-1 gp41 env Gene Encoding the Enfuvirtide (T-20) Target in HIV-1 Variants Harboring Multiple Antiretroviral Drug Resistance Mutations in the pol Gene

article

Increasing prevalence of transmitted drug resistance mutations and non-B subtype circulation in antiretroviral-naive chronically HIV-infected patients from 2001 to 2006/2007 in France

artículo científico publicado en 2010

Intensification of Antiretroviral Therapy through Addition of Enfuvirtide in Naive HIV-1-Infected Patients with Severe Immunosuppression Does Not Improve Immunological Response: Results of a Randomized Multicenter Trial (ANRS 130 Apollo) ⬇️

artículo científico publicado el 19 de noviembre de 2012

Interest of cytology combined with Xpert® HPV and Anyplex® II HPV28 Detection human papillomavirus (HPV) typing: differential profiles of anal and cervical HPV lesions in HIV-infected patients on antiretroviral therapy

scientific article published on 30 July 2018

Less frequent follow-up in routine care than in trials does not impact resistance selection in patients failing DRV/r or ATV/r first line treatment

artículo científico publicado en 2014

Levels of intracellular HIV-DNA in patients with suppressive antiretroviral therapy

artículo científico publicado en 2015

Long-lasting persistence of integrase resistance mutations in HIV-2-infected patients after raltegravir withdrawal.

artículo científico publicado en 2011

Long-term efficacy and safety of raltegravir, etravirine, and darunavir/ritonavir in treatment-experienced patients: week 96 results from the ANRS 139 TRIO trial

artículo científico publicado en 2012

Longitudinal analysis of raltegravir susceptibility and integrase replication capacity of human immunodeficiency virus type 1 during virologic failure

artículo científico publicado en 2009

Low genetic barrier to large increases in HIV-1 cross-resistance to protease inhibitors during salvage therapy

scientific article published on 01 January 2006

Minority resistant variants are also present in HIV-2-infected antiretroviral-naive patients

artículo científico publicado en 2018

Molecular determinants of HIV-2 R5-X4 tropism in the V3 loop: development of a new genotypic tool

artículo científico publicado en 2011

Multicenter comparison of the new Cobas 6800 system with Cobas Ampliprep/Cobas TaqMan and Abbott RealTime for the quantification of HIV, HBV and HCV viral load

artículo científico publicado en 2017

Multicenter quality control of hepatitis C virus protease inhibitor resistance genotyping

artículo científico publicado en 2013

Mutation V111I in HIV-2 reverse transcriptase increases the fitness of the nucleoside analogue-resistant K65R and Q151M viruses

artículo científico publicado en 2014

Mutational Correlates of Virological Failure in Individuals Receiving a WHO-Recommended Tenofovir-Containing First-Line Regimen: An International Collaboration

artículo científico publicado en 2017

Mutations Located outside the Integrase Gene Can Confer Resistance to HIV-1 Integrase Strand Transfer Inhibitors

artículo científico publicado en 2017

National sentinel surveillance of transmitted drug resistance in antiretroviral-naive chronically HIV-infected patients in France over a decade: 2001-2011.

artículo científico publicado en 2013

Natural evolution of CD4+ cell count in patients with CD4 >350 or >500  cells/mm3 at the time of diagnosis according to HIV-1 coreceptor tropism

artículo científico publicado en 2012

No impact of HIV-1 protease minority resistant variants on the virological response to a first-line PI-based regimen containing darunavir or atazanavir

artículo científico publicado en 2017

Nucleoside reverse transcriptase inhibitor resistance mutations associated with first-line stavudine-containing antiretroviral therapy: programmatic implications for countries phasing out stavudine

artículo científico publicado en 2013

Occurrence of Extensive Cutaneous Human Papillomavirus Infection After Initiation of Tofacitinib Therapy.

artículo científico publicado en 2019

Persistent low-level HIV-1 RNA between 20 and 50 copies/mL in antiretroviral-treated patients: associated factors and virological outcome

artículo científico publicado en 2012

Phenotypic analysis of HIV-1 E157Q integrase polymorphism and impact on virological outcome in patients initiating an integrase inhibitor-based regimen

artículo científico publicado en 2018

Pitfalls of antiretroviral drug resistance genotyping of HIV-1 Group M and Group N from Cameroon by sequenced-based assays

artículo científico publicado en 2015

Positive Virological Outcomes of HIV-Infected Patients on Protease Inhibitor-Based Second-Line Regimen in Cambodia: The ANRS 12276 2PICAM Study.

artículo científico publicado en 2018

Positive impact of HIV-1 gag cleavage site mutations on the virological response to darunavir boosted with ritonavir

artículo científico publicado en 2011

Pre-clinical development as microbicide of zinc tetra-ascorbo-camphorate, a novel terpenoid derivative: potent in vitro inhibitory activity against both R5- and X4-tropic HIV-1 strains without significant in vivo mucosal toxicity.

artículo científico publicado en 2008

Predictive value of liver enzymes and inflammatory biomarkers for the severity of liver fibrosis stage in HIV/HCV co-infected patients

artículo científico publicado en 2013

Prevalence of HIV-1 drug resistance among patients failing first-line ART in Monrovia, Liberia: a cross-sectional study

artículo científico publicado en 2015

Prevalence of gag mutations associated with in vitro resistance to capsid inhibitor GS-CA1 in HIV-1 antiretroviral-naive patients.

artículo científico publicado en 2017

Prevalence of respiratory viruses among adults, by season, age, respiratory tract region and type of medical unit in Paris, France, from 2011 to 2016

artículo científico publicado en 2017

Prevalence of subtype-related polymorphisms associated with in vitro resistance to attachment inhibitor BMS-626529 in HIV-1 'non-B'-infected patients

artículo científico publicado en 2012

Reply to Das and Berkhout, "How Polypurine Tract Changes in the HIV-1 RNA Genome Can Cause Resistance against the Integrase Inhibitor Dolutegravir".

artículo científico publicado en 2018

Residual HIV-1 RNA and HIV-1 Dna Production in the Genital Tract Reservoir of Women Treated with Haart: The Prospective Anrs Ep24 Gynodyn Study ⬇️

artículo científico publicado el 1 de enero de 2011

Resistance analyses in highly experienced patients failing raltegravir, etravirine and darunavir/ritonavir regimen ⬇️

artículo científico publicado el 13 de noviembre de 2010

Resistance profiles of emtricitabine and lamivudine in tenofovir-containing regimens

artículo científico publicado en 2012

Resistance to HIV Integrase Inhibitors: About R263K and E157Q Mutations

artículo científico publicado en 2018

Role and evolution of viral tropism in patients with advanced HIV disease receiving intensified initial regimen in the ANRS 130 APOLLO trial

artículo científico publicado en 2012

Role of baseline HIV-1 DNA level in highly-experienced patients receiving raltegravir, etravirine and darunavir/ritonavir regimen (ANRS139 TRIO trial).

artículo científico publicado en 2013

Role of minority populations of human immunodeficiency virus type 1 in the evolution of viral resistance to protease inhibitors.

scientific article published on April 2004

Short communication: Prevalence of HIV-1 transmitted drug resistance in Liberia

artículo científico publicado en 2014

Surveillance of Antiretroviral Drug Resistance Mutations in Untreated Young Children Living in the Central African Republic ⬇️

artículo científico publicado el 1 de enero de 2011

Sustained virological failure in Cameroonese patient infected by HIV-1 group N evidenced by sequence-based genotyping assay

artículo científico publicado en 2015

Switch as maintenance to elvitegravir/cobicistat/emtricitabine/tenofovir disoproxil fumarate: week 48 results in a clinical cohort

artículo científico publicado en 2017

Tenofovir plasma concentrations related to estimated glomerular filtration rate changes in first-line regimens in African HIV-infected patients: ANRS 12115 DAYANA substudy

artículo científico publicado en 2015

The HIV-1 integrase G118R mutation confers raltegravir resistance to the CRF02_AG HIV-1 subtype.

artículo científico publicado en 2011

Tipranavir-ritonavir genotypic resistance score in protease inhibitor-experienced patients

artículo científico publicado en 2008

Transmitted drug resistance in French HIV-2-infected patients

artículo científico publicado en 2013

Tropism distribution among antiretroviral-naive HIV-2-infected patients

artículo científico publicado en 2015

Use of PCR Signal and Therapeutic Drug Monitoring in a Switch Cohort Study to Tenofovir/Emtricitabine/Rilpivirine: A W96 Follow-Up

artículo científico publicado en 2015

Usefulness of a genotypic resistance test using dried blood spot specimens in African HIV-infected children with virological failure according to the 2010-revised WHO criteria ⬇️

artículo científico publicado el 11 de abril de 2011

Usefulness of multiplex PCR methods and respiratory viruses' distribution in children below 15 years old according to age, seasons and clinical units in France: A 3 years retrospective study

artículo científico publicado en 2017

Virological Response and Resistance Profiles After 18 to 30 Months of First- or Second-/Third-Line Antiretroviral Treatment: A Cross-Sectional Evaluation in HIV Type 1-Infected Children Living in the Central African Republic ⬇️

artículo científico publicado el 20 de junio de 2011

Virological Response and Resistance Profiles After 24 Months of First-Line Antiretroviral Treatment in Adults Living in Bangui, Central African Republic ⬇️

artículo científico publicado el 23 de septiembre de 2011

Virological failure and HIV type 1 drug resistance profiles among patients followed-up in private sector, Douala, Cameroon

artículo científico publicado en 2010

Virological outcome at week 48 of three recommended first-line regimens using ultrasensitive viral load and plasma drug assay

artículo científico publicado en 2014

Zika virus in the female genital tract

artículo científico publicado en 2016

Dominio Público Uruguay está sostenido por:

Acerca de Dominio Público Uruguay

Ayuda